FDA cancels drug sale licences of Cipla Pharma & Life Sciences' Pune Carry and Forwarding unit
India’s Food and Drug Administration has revoked the drug‑sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit. Inspectors reported that medicines were kept directly on the floor and identified lapses in procedures for managing expired stock. The regulator said the violations breached safety standards, prompting the cancellation. The decision affects the unit’s ability to distribute pharmaceutical products nationwide.